0001209191-19-042341.txt : 20190717
0001209191-19-042341.hdr.sgml : 20190717
20190717130123
ACCESSION NUMBER: 0001209191-19-042341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190715
FILED AS OF DATE: 20190717
DATE AS OF CHANGE: 20190717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Jason Douglas
CENTRAL INDEX KEY: 0001662395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 19958646
MAIL ADDRESS:
STREET 1: C/O REATA PHARMACEUTICALS, INC.
STREET 2: 2801 GATEWAY DR. SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-15
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001662395
Wilson Jason Douglas
2801 GATEWAY DRIVE
SUITE 150
IRVING
TX
75063
0
1
0
0
Chief Financial Officer
Class A common stock
2019-07-15
4
C
0
4000
A
4000
D
Class A common stock
2019-07-15
4
S
0
1811
83.9288
D
2189
D
Class A common stock
2019-07-15
4
S
0
989
84.7301
D
1200
D
Class A common stock
2019-07-15
4
S
0
1200
85.6357
D
0
D
Employee Stock Option (right to buy)
11.00
2019-07-15
4
M
0
4000
0.00
D
2026-05-25
Class B common stock
4000
58881
D
Class B common stock
2019-07-15
4
M
0
4000
11.00
A
Class A common stock
4000
47646
D
Class B common stock
2019-07-15
4
C
0
4000
D
Class A common stock
4000
43646
D
The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018.
The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.51 to $84.26. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.51 to $85.11. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.52 to $86.46. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The options, representing a right to purchase a total of 101,881 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016, subject to continued service through each vesting date.
/s/ Tracy Herson, attorney-in-fact
2019-07-17